State NY
Clinical Trials in New York
Recruiting clinical trials with at least one study location in New York. Data updated daily from ClinicalTrials.gov.
Top Conditions in New York
NCT07219966 Phase 3
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disor...
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
NCT05977751 N/A
Recruiting
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Condition
Contraception
Enrollment
573 pts
Location
United States
Sponsor
Femasys Inc.
NCT06981429 N/A
Recruiting
A Positive Food Parenting Intervention to Promote Healthy Growth in Children at ...
Condition
Pediatric Obesity
Enrollment
36 pts
Location
United States
Sponsor
State University of New York a
NCT07140731 N/A
Recruiting
The Symani Restore Study
Condition
Moyamoya Disease
Enrollment
15 pts
Location
United States
Sponsor
Jacobs institute
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT07225686 Phase 3
Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sl...
Condition
Obesity
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT05354505 N/A
Recruiting
Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic He...
Condition
Diaphragmatic Hernia
Enrollment
10 pts
Location
United States
Sponsor
Vincent Duron
NCT06872905 N/A
Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endopros...
Condition
Aortoiliac Occlusive Disease
Enrollment
158 pts
Location
United States, Italy, Netherlands
Sponsor
W.L.Gore & Associates
NCT06991556 Phase 2
Recruiting
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone ...
Condition
Metastatic Hormone-sensitive Prostate Cancer
Enrollment
150 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
NCT03514602 N/A
Recruiting
Maternal Smoking Cessation and Pediatric Obesity Prevention
Condition
Childhood Obesity
Enrollment
48 pts
Location
United States
Sponsor
State University of New York a
NCT07078253 N/A
Recruiting
Improving Food Access in East Flatbush Through a Community Partner Coalition in ...
Condition
Food Insecurity
Enrollment
100 pts
Location
United States
Sponsor
NYU Langone Health
NCT05504837 Phase 1
Recruiting
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Condition
Cystic Fibrosis
Enrollment
12 pts
Location
United States
Sponsor
Krystal Biotech, Inc.
NCT05477901 N/A
Recruiting
Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)
Condition
Inflammation
Enrollment
450 pts
Location
United States, Brazil
Sponsor
New York State Psychiatric Ins
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarco...
Condition
Alveolar Soft Part Sarcoma
Enrollment
325 pts
Location
United States, China, Italy
Sponsor
Advenchen Laboratories, LLC
NCT06801067 Phase 1
Recruiting
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Condition
Diarrhea
Enrollment
15 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06848231 Phase 2
Recruiting
A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
Condition
Multiple System Atrophy
Enrollment
75 pts
Location
United States, Japan, Taiwan
Sponsor
Yoda Therapeutics Inc.
NCT06116253 N/A
Recruiting
Advanced Diffusion Imaging in Renal Cancer Patients
Condition
Renal Cancer
Enrollment
90 pts
Location
United States
Sponsor
NYU Langone Health
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants Wit...
Condition
Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canada
Sponsor
Inmagene LLC
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The ...
Condition
Advanced Breast Carcinoma
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT06071845 N/A
Recruiting
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of E...
Condition
Barrett Esophagus
Enrollment
400 pts
Location
United States
Sponsor
Mayo Clinic
NCT07216872 N/A
Recruiting
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation...
Condition
Alcohol Use Disorder
Enrollment
186 pts
Location
United States, Israel
Sponsor
Brainsway
NCT06292780 Phase 1, Phase 2
Recruiting
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or R...
Condition
Relapsed/Refractory Systemic Light Chain Amyloidosis
Enrollment
220 pts
Location
United States, South Korea, Spain
Sponsor
Regeneron Pharmaceuticals
NCT05546580 Phase 1
Recruiting
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyr...
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
50 pts
Location
United States
Sponsor
Oryzon Genomics S.A.
NCT06118086 Phase 1, Phase 2
Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid...
Condition
Adenoid Cystic Carcinoma
Enrollment
100 pts
Location
United States, France
Sponsor
Remix Therapeutics